nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—GABRA3—Graves' disease	0.584	1	CbGaD
Flurazepam—CYP2A6—Methimazole—Graves' disease	0.158	0.538	CbGbCtD
Flurazepam—CYP2E1—Methimazole—Graves' disease	0.104	0.355	CbGbCtD
Flurazepam—CYP3A4—Methimazole—Graves' disease	0.0317	0.108	CbGbCtD
Flurazepam—GABRQ—GABA A receptor activation—GABRA3—Graves' disease	0.00343	0.0403	CbGpPWpGaD
Flurazepam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00282	0.0332	CbGpPWpGaD
Flurazepam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00278	0.0327	CbGpPWpGaD
Flurazepam—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00263	0.0309	CbGpPWpGaD
Flurazepam—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.0026	0.0305	CbGpPWpGaD
Flurazepam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00238	0.0279	CbGpPWpGaD
Flurazepam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00231	0.0271	CbGpPWpGaD
Flurazepam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00223	0.0262	CbGpPWpGaD
Flurazepam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00221	0.026	CbGpPWpGaD
Flurazepam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0022	0.0259	CbGpPWpGaD
Flurazepam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00217	0.0256	CbGpPWpGaD
Flurazepam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0021	0.0247	CbGpPWpGaD
Flurazepam—GABRQ—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0021	0.0247	CbGpPWpGaD
Flurazepam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.0019	0.0223	CbGpPWpGaD
Flurazepam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00173	0.0203	CbGpPWpGaD
Flurazepam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0017	0.02	CbGpPWpGaD
Flurazepam—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00161	0.0189	CbGpPWpGaD
Flurazepam—Drowsiness—Methimazole—Graves' disease	0.00161	0.0693	CcSEcCtD
Flurazepam—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00159	0.0187	CbGpPWpGaD
Flurazepam—Agranulocytosis—Methimazole—Graves' disease	0.0015	0.0647	CcSEcCtD
Flurazepam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00146	0.0171	CbGpPWpGaD
Flurazepam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00141	0.0166	CbGpPWpGaD
Flurazepam—Drowsiness—Propylthiouracil—Graves' disease	0.00137	0.0589	CcSEcCtD
Flurazepam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00136	0.016	CbGpPWpGaD
Flurazepam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00136	0.0159	CbGpPWpGaD
Flurazepam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00133	0.0156	CbGpPWpGaD
Flurazepam—Agranulocytosis—Propylthiouracil—Graves' disease	0.00128	0.055	CcSEcCtD
Flurazepam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00117	0.0137	CbGpPWpGaD
Flurazepam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00116	0.0137	CbGpPWpGaD
Flurazepam—Leukopenia—Methimazole—Graves' disease	0.00112	0.0485	CcSEcCtD
Flurazepam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00111	0.0131	CbGpPWpGaD
Flurazepam—GABRQ—GABA receptor activation—GABRA3—Graves' disease	0.00111	0.0131	CbGpPWpGaD
Flurazepam—Arthralgia—Methimazole—Graves' disease	0.00107	0.0461	CcSEcCtD
Flurazepam—Dysgeusia—Propylthiouracil—Graves' disease	0.00105	0.0451	CcSEcCtD
Flurazepam—Leukopenia—Propylthiouracil—Graves' disease	0.000956	0.0412	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methimazole—Graves' disease	0.000934	0.0403	CcSEcCtD
Flurazepam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.000918	0.0108	CbGpPWpGaD
Flurazepam—Somnolence—Methimazole—Graves' disease	0.000911	0.0393	CcSEcCtD
Flurazepam—Arthralgia—Propylthiouracil—Graves' disease	0.000909	0.0392	CcSEcCtD
Flurazepam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.000904	0.0106	CbGpPWpGaD
Flurazepam—Dyspepsia—Methimazole—Graves' disease	0.000902	0.0389	CcSEcCtD
Flurazepam—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.000855	0.0101	CbGpPWpGaD
Flurazepam—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.000844	0.00992	CbGpPWpGaD
Flurazepam—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.000794	0.0342	CcSEcCtD
Flurazepam—GABRR3—eye—Graves' disease	0.000789	0.111	CbGeAlD
Flurazepam—Somnolence—Propylthiouracil—Graves' disease	0.000775	0.0334	CcSEcCtD
Flurazepam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.000772	0.00908	CbGpPWpGaD
Flurazepam—Dyspepsia—Propylthiouracil—Graves' disease	0.000767	0.0331	CcSEcCtD
Flurazepam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.00075	0.00882	CbGpPWpGaD
Flurazepam—Pruritus—Methimazole—Graves' disease	0.000725	0.0313	CcSEcCtD
Flurazepam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.000724	0.00851	CbGpPWpGaD
Flurazepam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000719	0.00845	CbGpPWpGaD
Flurazepam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000706	0.0083	CbGpPWpGaD
Flurazepam—GABRR2—eye—Graves' disease	0.000684	0.096	CbGeAlD
Flurazepam—GABRR1—eye—Graves' disease	0.000659	0.0924	CbGeAlD
Flurazepam—Vomiting—Methimazole—Graves' disease	0.000652	0.0281	CcSEcCtD
Flurazepam—GABRQ—Orphan transporters—GABRA3—Graves' disease	0.00065	0.00764	CbGpPWpGaD
Flurazepam—Rash—Methimazole—Graves' disease	0.000646	0.0279	CcSEcCtD
Flurazepam—Dermatitis—Methimazole—Graves' disease	0.000646	0.0278	CcSEcCtD
Flurazepam—Headache—Methimazole—Graves' disease	0.000642	0.0277	CcSEcCtD
Flurazepam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000617	0.00726	CbGpPWpGaD
Flurazepam—Pruritus—Propylthiouracil—Graves' disease	0.000617	0.0266	CcSEcCtD
Flurazepam—Nausea—Methimazole—Graves' disease	0.000609	0.0263	CcSEcCtD
Flurazepam—Vomiting—Propylthiouracil—Graves' disease	0.000554	0.0239	CcSEcCtD
Flurazepam—Rash—Propylthiouracil—Graves' disease	0.000549	0.0237	CcSEcCtD
Flurazepam—Dermatitis—Propylthiouracil—Graves' disease	0.000549	0.0237	CcSEcCtD
Flurazepam—Headache—Propylthiouracil—Graves' disease	0.000546	0.0235	CcSEcCtD
Flurazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000537	0.00631	CbGpPWpGaD
Flurazepam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000535	0.00629	CbGpPWpGaD
Flurazepam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000527	0.00619	CbGpPWpGaD
Flurazepam—Nausea—Propylthiouracil—Graves' disease	0.000518	0.0223	CcSEcCtD
Flurazepam—GABRG3—pituitary gland—Graves' disease	0.000513	0.072	CbGeAlD
Flurazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000512	0.00602	CbGpPWpGaD
Flurazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000512	0.00602	CbGpPWpGaD
Flurazepam—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000499	0.00586	CbGpPWpGaD
Flurazepam—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000492	0.00579	CbGpPWpGaD
Flurazepam—Clonazepam—GABRA3—Graves' disease	0.000491	0.0819	CrCbGaD
Flurazepam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000478	0.00562	CbGpPWpGaD
Flurazepam—Chloroquine—TNF—Graves' disease	0.000461	0.0768	CrCbGaD
Flurazepam—Clotiazepam—GABRA3—Graves' disease	0.000456	0.076	CrCbGaD
Flurazepam—GABRQ—Ion channel transport—GABRA3—Graves' disease	0.000456	0.00536	CbGpPWpGaD
Flurazepam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000456	0.00536	CbGpPWpGaD
Flurazepam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.00045	0.00529	CbGpPWpGaD
Flurazepam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000438	0.00514	CbGpPWpGaD
Flurazepam—Alprazolam—GABRA3—Graves' disease	0.000431	0.0718	CrCbGaD
Flurazepam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000422	0.00496	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000422	0.00496	CbGpPWpGaD
Flurazepam—Cinolazepam—GABRA3—Graves' disease	0.00042	0.07	CrCbGaD
Flurazepam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.00042	0.00493	CbGpPWpGaD
Flurazepam—Quazepam—GABRA3—Graves' disease	0.000418	0.0696	CrCbGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000416	0.00488	CbGpPWpGaD
Flurazepam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000412	0.00484	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000404	0.00474	CbGpPWpGaD
Flurazepam—GABRB1—pituitary gland—Graves' disease	0.000397	0.0556	CbGeAlD
Flurazepam—Flunitrazepam—GABRA3—Graves' disease	0.000394	0.0658	CrCbGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000393	0.00462	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000388	0.00456	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000385	0.00453	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000385	0.00453	CbGpPWpGaD
Flurazepam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000375	0.00441	CbGpPWpGaD
Flurazepam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.00037	0.00435	CbGpPWpGaD
Flurazepam—Estazolam—GABRA3—Graves' disease	0.000369	0.0615	CrCbGaD
Flurazepam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.00036	0.00423	CbGpPWpGaD
Flurazepam—Halazepam—GABRA3—Graves' disease	0.000358	0.0598	CrCbGaD
Flurazepam—GABRA4—pituitary gland—Graves' disease	0.000358	0.0502	CbGeAlD
Flurazepam—GABRP—pituitary gland—Graves' disease	0.000355	0.0499	CbGeAlD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000355	0.00417	CbGpPWpGaD
Flurazepam—Adinazolam—GABRA3—Graves' disease	0.000351	0.0585	CrCbGaD
Flurazepam—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.00035	0.00411	CbGpPWpGaD
Flurazepam—Fludiazepam—GABRA3—Graves' disease	0.000348	0.058	CrCbGaD
Flurazepam—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000345	0.00406	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000345	0.00405	CbGpPWpGaD
Flurazepam—Prazepam—GABRA3—Graves' disease	0.00034	0.0566	CrCbGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000333	0.00391	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000331	0.00389	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000325	0.00382	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000317	0.00373	CbGpPWpGaD
Flurazepam—GABRA3—thyroid gland—Graves' disease	0.000317	0.0444	CbGeAlD
Flurazepam—Triazolam—GABRA3—Graves' disease	0.000316	0.0527	CrCbGaD
Flurazepam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000316	0.00371	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000312	0.00367	CbGpPWpGaD
Flurazepam—GABRB3—eye—Graves' disease	0.00031	0.0435	CbGeAlD
Flurazepam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.000309	0.00364	CbGpPWpGaD
Flurazepam—CYP2A6—adipose tissue—Graves' disease	0.000308	0.0433	CbGeAlD
Flurazepam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000307	0.00361	CbGpPWpGaD
Flurazepam—Temazepam—GABRA3—Graves' disease	0.000303	0.0505	CrCbGaD
Flurazepam—GABRG2—pituitary gland—Graves' disease	0.000299	0.042	CbGeAlD
Flurazepam—GABRB3—connective tissue—Graves' disease	0.000298	0.0419	CbGeAlD
Flurazepam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000296	0.00348	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000296	0.00347	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000295	0.00347	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—GABRA3—Graves' disease	0.000295	0.00347	CbGpPWpGaD
Flurazepam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000294	0.00346	CbGpPWpGaD
Flurazepam—Midazolam—GABRA3—Graves' disease	0.000293	0.0489	CrCbGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000292	0.00343	CbGpPWpGaD
Flurazepam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000289	0.0034	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000284	0.00334	CbGpPWpGaD
Flurazepam—GABRA2—adipose tissue—Graves' disease	0.000272	0.0382	CbGeAlD
Flurazepam—GABRE—pituitary gland—Graves' disease	0.000271	0.0381	CbGeAlD
Flurazepam—GABRE—adipose tissue—Graves' disease	0.00027	0.0379	CbGeAlD
Flurazepam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000267	0.00314	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000259	0.00305	CbGpPWpGaD
Flurazepam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000253	0.00297	CbGpPWpGaD
Flurazepam—Diazepam—GABRA3—Graves' disease	0.000251	0.0419	CrCbGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00025	0.00294	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000249	0.00292	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000244	0.00287	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000243	0.00286	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000239	0.00281	CbGpPWpGaD
Flurazepam—GABRE—thyroid gland—Graves' disease	0.000234	0.0328	CbGeAlD
Flurazepam—GABRB3—pituitary gland—Graves' disease	0.00023	0.0323	CbGeAlD
Flurazepam—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000226	0.00266	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000224	0.00263	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000213	0.00251	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000205	0.0024	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000199	0.00234	CbGpPWpGaD
Flurazepam—GABRB3—thyroid gland—Graves' disease	0.000198	0.0278	CbGeAlD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000196	0.0023	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000192	0.00225	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.00019	0.00224	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000187	0.0022	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000166	0.00195	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000164	0.00192	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000159	0.00186	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000159	0.00186	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—GABRA3—Graves' disease	0.00015	0.00176	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000131	0.00154	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000129	0.00151	CbGpPWpGaD
Flurazepam—CYP2E1—thyroid gland—Graves' disease	0.000126	0.0177	CbGeAlD
Flurazepam—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000122	0.00143	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00012	0.00141	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000112	0.00132	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00011	0.00129	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD40—Graves' disease	0.00011	0.00129	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000108	0.00127	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000107	0.00126	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000103	0.00121	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000102	0.0012	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000101	0.00118	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	8.92e-05	0.00105	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.79e-05	0.00103	CbGpPWpGaD
Flurazepam—ABCB1—pituitary gland—Graves' disease	8.33e-05	0.0117	CbGeAlD
Flurazepam—ABCB1—adipose tissue—Graves' disease	8.3e-05	0.0116	CbGeAlD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.07e-05	0.000949	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-B—Graves' disease	8.01e-05	0.000942	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—FASLG—Graves' disease	7.83e-05	0.00092	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—FAS—Graves' disease	7.55e-05	0.000887	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL2RA—Graves' disease	7.51e-05	0.000882	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-A—Graves' disease	7.42e-05	0.000872	CbGpPWpGaD
Flurazepam—ABCB1—thyroid gland—Graves' disease	7.18e-05	0.0101	CbGeAlD
Flurazepam—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	6.78e-05	0.000797	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.11e-05	0.000601	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IFNG—Graves' disease	4.95e-05	0.000582	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL1B—Graves' disease	4.42e-05	0.000519	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	4.41e-05	0.000518	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GC—Graves' disease	4.07e-05	0.000478	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	3.86e-05	0.000454	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GC—Graves' disease	3.73e-05	0.000439	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	3.73e-05	0.000438	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	3.71e-05	0.000436	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—Graves' disease	3.21e-05	0.000377	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—B3GNT2—Graves' disease	3.08e-05	0.000362	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GC—Graves' disease	2.95e-05	0.000347	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—B3GNT2—Graves' disease	2.83e-05	0.000332	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—B3GNT2—Graves' disease	2.24e-05	0.000263	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GC—Graves' disease	2.22e-05	0.000261	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—B3GNT2—Graves' disease	1.68e-05	0.000198	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	1.58e-05	0.000186	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GC—Graves' disease	1.37e-05	0.000161	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.04e-05	0.000122	CbGpPWpGaD
